within Pharmacolibrary.Drugs.ATC.D;

model D07XB02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 5.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 15 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.058,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07XB02</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamcinolone is a synthetic corticosteroid used for its anti-inflammatory and immunosuppressive properties. It is approved and widely used today in topical, inhaled, injectable, and intranasal forms for the treatment of various conditions such as allergic disorders, skin diseases, arthritic conditions, and for asthma and hay fever.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for adults following dermal (topical) application; specific PK values for topical administration are rarely published, and data reported here are best estimates based on published intravenous and oral formulations, and corticosteroid class.</p><h4>References</h4><ol><li><p>Altamirano-Vallejo, JC, et al., &amp; Santos, A (2018). Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 34(5) 416–425. DOI:<a href=&quot;https://doi.org/10.1089/jop.2017.0099&quot;>10.1089/jop.2017.0099</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29584529/&quot;>https://pubmed.ncbi.nlm.nih.gov/29584529</a></p></li><li><p>Callen, JP (1981). Intralesional corticosteroids. <i>Journal of the American Academy of Dermatology</i> 4(2) 149–151. DOI:<a href=&quot;https://doi.org/10.1016/s0190-9622(81)70017-3&quot;>10.1016/s0190-9622(81)70017-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7217384/&quot;>https://pubmed.ncbi.nlm.nih.gov/7217384</a></p></li><li><p>Szefler, SJ (2001). Pharmacokinetics of intranasal corticosteroids. <i>The Journal of allergy and clinical immunology</i> 108(1 Suppl) S26–S31. DOI:<a href=&quot;https://doi.org/10.1067/mai.2001.115563&quot;>10.1067/mai.2001.115563</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11449203/&quot;>https://pubmed.ncbi.nlm.nih.gov/11449203</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07XB02;
